Cargando…
Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
BACKGROUND: The effects of β blockers on the primary prevention of anthracycline-induced cardiotoxicity were controversial. METHODS: We searched PubMed, Embase and Cochrane Library for randomized controlled trials of the comparison of β blockers versus placebo in patients undergoing anthracycline ch...
Autores principales: | Ma, Yingxu, Bai, Fan, Qin, Fen, Li, Jiayi, Liu, Na, Li, Dongping, Li, Tengfang, Xie, Hui, Liu, Da, Zhou, Shenghua, Liu, Qiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485127/ https://www.ncbi.nlm.nih.gov/pubmed/31023386 http://dx.doi.org/10.1186/s40360-019-0298-6 |
Ejemplares similares
-
Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trials
por: Ma, Yingxu, et al.
Publicado: (2018) -
Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
por: He, Dongsheng, et al.
Publicado: (2022) -
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
por: Ayuna, Ahmed, et al.
Publicado: (2020) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016)